Data for (Study ST002949)
(Analysis AN004836)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 |
---|---|---|
1,1^-(Tetrahydro-6a-hydroxy-2,3a,5-trimethylfuro[2,3-d]-1,3-dioxole-2,5-diyl)bis-ethanone | 1.8276 | 0.0861 |
1-Methylnicotinamide | 1.6356 | 0.3103 |
2-Benzofurancarboxaldehyde | 1.0327 | 0.9673 |
3-Amino-2-piperidone | 0.8541 | 1.1459 |
4-Hydroxybenzaldehyde | 0.7465 | 1.2487 |
(±)-Tryptophan | 0.8893 | 1.1042 |
Betaine aldehyde | 1.0790 | 0.9195 |
Hypoxanthine | 1.6356 | 0.3103 |
Indoleacetaldehyde | 1.0742 | 0.9258 |
L-Carnitine | 1.1582 | 0.8388 |
L-Gulose | 0.9014 | 1.0986 |
L-Tyrosine | 0.7427 | 1.2624 |
LysoPE(16:0/0:0) | 0.8563 | 1.1408 |
Octadecylamine | 1.4396 | 0.5604 |
PC(16:0/16:0) | 0.0267 | 1.9366 |
PC(20:3(8Z,11Z,14Z)/20:1(11Z)) | 1.0689 | 0.9284 |
Phytosphingosine | 1.1152 | 0.8803 |
Pipecolic acid | 0.9095 | 1.0905 |
Pyro-L-glutaminyl-L-glutamine | 0.8055 | 1.2021 |
threo-Syringoylglycerol | 1.5682 | 0.2966 |
Factors:
F1 | Treatment:Ankylosing Spondylitis |
F2 | Treatment:healthy control |